Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pediatric-Like ALL Chemotherapy for Adult Lymphoblastic Lymphoma (LL03)
NCT00195871Phase 2Unknown
- Sponsor
- Centre Henri Becquerel
- Start
- Feb 2004
- Primary completion
- Jun 2014
- Modality
- Nucleic Acid-Directed Small Molecules, Orthosteric Ligands, Replacement Enzymes
- Countries
- 2
01
Overview
A Phase 2 trial of prednisone, vincristine, daunorubicin, cyclophosphamide, asparaginase escherichia coli in lymphoblastic lymphoma (LL), sponsored by Centre Henri Becquerel. Status: unknown.
02
Drugs
prednisonevincristinedaunorubicincyclophosphamideasparaginase escherichia coli
03
Conditions
lymphoblastic lymphoma (LL)
Beyond the preview
Go deeper on NCT00195871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00195871.